Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,594 | 268 | 93.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130.11 | 7 | 3.4% |
| Education | $117.79 | 5 | 3.1% |
| Gift | $10.96 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $500.58 | 28 | $0 (2020) |
| ABBVIE INC. | $438.58 | 40 | $0 (2023) |
| GENZYME CORPORATION | $313.41 | 19 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $312.42 | 26 | $0 (2018) |
| Genentech USA, Inc. | $263.86 | 18 | $0 (2018) |
| Allergan, Inc. | $226.41 | 42 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $189.29 | 14 | $0 (2018) |
| GE HEALTHCARE | $138.16 | 1 | $0 (2017) |
| Acorda Therapeutics, Inc | $130.11 | 7 | $0 (2019) |
| UCB, Inc. | $123.91 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.03 | 1 | ABBVIE INC. ($16.03) |
| 2022 | $11.84 | 1 | EMD Serono, Inc. ($11.84) |
| 2021 | $374.52 | 37 | AbbVie Inc. ($348.81) |
| 2020 | $251.16 | 43 | Allergan, Inc. ($175.77) |
| 2019 | $141.74 | 10 | GENZYME CORPORATION ($41.64) |
| 2018 | $977.31 | 63 | Biogen, Inc. ($210.14) |
| 2017 | $2,080 | 126 | Biogen, Inc. ($273.33) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.84 | General |
| 12/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $11.70 | General |
| 06/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 19 | 1,144 | 4,393 | $606,930 | $283,737 |
| 2020 | 20 | 1,257 | 4,360 | $609,715 | $282,604 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2021 | 16 | 2,710 | $304,875 | $86,490 | 28.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 308 | 709 | $107,050 | $74,884 | 70.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 101 | 101 | $25,310 | $18,918 | 74.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 78 | 102 | $20,510 | $14,707 | 71.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 61 | 63 | $17,640 | $10,954 | 62.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 32 | 32 | $14,700 | $10,660 | 72.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 102 | $16,320 | $9,110 | 55.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 22 | 22 | $12,430 | $8,293 | 66.7% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Office | 2021 | 30 | 31 | $11,000 | $7,872 | 71.6% |
| 95957 | Digital analysis of electrical brain wave activity (eeg) | Office | 2021 | 27 | 27 | $10,530 | $6,283 | 59.7% |
| 96132 | Neuropsychological testing evaluation by qualified health care professional, first 60 minutes | Office | 2021 | 49 | 50 | $7,625 | $5,473 | 71.8% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 29 | 30 | $7,650 | $4,444 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 54 | $6,270 | $4,049 | 64.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $5,500 | $3,625 | 65.9% |
| 95957 | Digital analysis of electrical brain wave activity (eeg) | Facility | 2021 | 31 | 31 | $4,650 | $2,837 | 61.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 19 | 21 | $4,200 | $2,745 | 65.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 22 | 38 | $8,190 | $2,503 | 30.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 36 | $3,600 | $2,282 | 63.4% |
| 96138 | Psychological or neuropsychological test administration and scoring by technician, first 30 minutes | Office | 2021 | 50 | 51 | $2,600 | $1,727 | 66.4% |
| 96139 | Psychological or neuropsychological test administration and scoring by technician, additional 30 minutes | Office | 2021 | 50 | 51 | $2,600 | $1,727 | 66.4% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 12 | 21 | $4,420 | $1,439 | 32.6% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2021 | 19 | 58 | $6,380 | $1,114 | 17.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 20 | 20 | $2,000 | $1,036 | 51.8% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 11 | 11 | $880.00 | $566.06 | 64.3% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2020 | 12 | 2,600 | $292,500 | $83,429 | 28.5% |
About Dr. Rene Gomez, MD
Dr. Rene Gomez, MD is a Specialist healthcare provider based in Lawrenceville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255316766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rene Gomez, MD has received a total of $3,853 in payments from pharmaceutical and medical device companies, with $16.03 received in 2023. These payments were reported across 281 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,594).
As a Medicare-enrolled provider, Gomez has provided services to 2,401 Medicare beneficiaries, totaling 8,753 services with total Medicare billing of $566,341. Data is available for 2 years (2020–2021), covering 47 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Lawrenceville, NJ
- Active Since 12/08/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1255316766
Products in Payments
- UBRELVY (Drug) $506.75
- TYSABRI (Biological) $344.59
- OCREVUS (Biological) $262.69
- LEMTRADA (Drug) $224.58
- COPAXONE (Drug) $216.69
- ONZETRA Xsail (Drug) $174.51
- DATSCAN (Drug) $138.16
- AMPYRA (Drug) $115.58
- Rebif (Biological) $96.89
- Briviact (Drug) $93.36
- AUBAGIO (Drug) $88.83
- SOLIRIS (Drug) $80.57
- Fycompa (Drug) $72.43
- Zinbryta (Biological) $60.11
- GILENYA (Drug) $58.86
- TROKENDI XR (Drug) $58.33
- NUPLAZID (Drug) $57.74
- Aimovig (Biological) $53.67
- BOTOX (Biological) $47.87
- AMYVID (Drug) $47.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lawrenceville
Dr. Glenn Parris, M.d, M.D
Specialist — Payments: $43,182
Steven Safran, M.d, M.D
Specialist — Payments: $42,385
Dr. Debra Miller, Md, MD
Specialist — Payments: $10,188
Dr. Arun Lakhanpal, M.d, M.D
Specialist — Payments: $5,387
Dr. John Gargus, Md, MD
Specialist — Payments: $4,308
Dr. Angana Shah, M.d, M.D
Specialist — Payments: $3,878